Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL7459955

C1CC2CCC1CC2.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA7 P43166 1/20 0.33
CA13 Q8N1Q1 1/20 0.33
TSHR P16473 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1090001-A4 (HETEROCYCLIC)METHYL SUBSTITUTED CARBAPENEM ANTIBACTERIALS MERCK & CO INC (US) 2002-11-27 EP disclosed
EP-1090000-A4 NAPHTHO 1,8-DE]THIASIN-2-YL METHYL CARBAPENEM ANTIBACTERIALS MERCK & CO INC (US) 2002-11-27 EP disclosed
EP-1090001-A1 (HETEROCYCLIC)METHYL SUBSTITUTED CARBAPENEM ANTIBACTERIALS Merck & Co., Inc. (US) 2001-04-11 EP disclosed
EP-1090000-A1 NAPHTHO 1,8-DE]THIASIN-2-YL METHYL CARBAPENEM ANTIBACTERIALS Merck & Co., Inc. (US) 2001-04-11 EP disclosed
WO-1999067240-A1 (HETEROCYCLIC)METHYL SUBSTITUTED CARBAPENEM ANTIBACTERIALS MERCK & CO., INC. (US) 1999-12-29 WO disclosed
WO-1999067242-A1 NAPHTHO[1,8-DE]THIASIN-2-YL METHYL CARBAPENEM ANTIBACTERIALS MERCK & CO., INC. (US) 1999-12-29 WO disclosed